Glaucoma awareness program and treatment adherence
Part of Eyes & vision clinical trials.
This study tests whether a glaucoma awareness program helps people stick to their treatment plan. If you have glaucoma and go to follow-up visits at the study hospital, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with glaucoma.
- You go for follow-up appointments at the study hospital.
- You can understand and agree to take part in the study.
- You can communicate in Nepali.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a village-based approach to bring eye care closer to older community members. If you live in the right area and are willing to participate, it may help improve access to eye screening and services.
This trial tests whether a home-based exercise program can lower eye pressure and protect the optic nerve in people with glaucoma. It is designed for patients whose eye pressure is already controlled by medication.
This study follows patients over time to see how well different glaucoma treatments (medications, laser, or surgery) work. It may help doctors learn which treatments are best for managing glaucoma and high eye pressure.
This study tests if telemedicine can help find glaucoma and other eye problems early. It may help people who speak one of several languages and want to check their eye health from home.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.